Global Prostate-specific Antigen (PSA) Testing Market Research Report 2024(Status and Outlook)
Report Overview:
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la
The Global Prostate-specific Antigen (PSA) Testing Market Size was estimated at USD 530.63 million in 2023 and is projected to reach USD 629.92 million by 2029, exhibiting a CAGR of 2.90% during the forecast period.
This report provides a deep insight into the global Prostate-specific Antigen (PSA) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Prostate-specific Antigen (PSA) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Prostate-specific Antigen (PSA) Testing market in any manner.
Global Prostate-specific Antigen (PSA) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck?Co.
Medtronic
Sanofi-Aventis SA
Market Segmentation (by Type)
CLIA Method
ELISA Method
Market Segmentation (by Application)
Screening
Post-treatment Monitoring
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prostate-specific Antigen (PSA) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK4 gene.
The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a la
The Global Prostate-specific Antigen (PSA) Testing Market Size was estimated at USD 530.63 million in 2023 and is projected to reach USD 629.92 million by 2029, exhibiting a CAGR of 2.90% during the forecast period.
This report provides a deep insight into the global Prostate-specific Antigen (PSA) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Prostate-specific Antigen (PSA) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Prostate-specific Antigen (PSA) Testing market in any manner.
Global Prostate-specific Antigen (PSA) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck?Co.
Medtronic
Sanofi-Aventis SA
Market Segmentation (by Type)
CLIA Method
ELISA Method
Market Segmentation (by Application)
Screening
Post-treatment Monitoring
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Prostate-specific Antigen (PSA) Testing Market
- Overview of the regional outlook of the Prostate-specific Antigen (PSA) Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prostate-specific Antigen (PSA) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Prostate-specific Antigen (PSA) Testing
1.2 Key Market Segments
1.2.1 Prostate-specific Antigen (PSA) Testing Segment by Type
1.2.2 Prostate-specific Antigen (PSA) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Prostate-specific Antigen (PSA) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Prostate-specific Antigen (PSA) Testing Sales by Manufacturers (2019-2024)
3.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Prostate-specific Antigen (PSA) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Prostate-specific Antigen (PSA) Testing Sales Sites, Area Served, Product Type
3.6 Prostate-specific Antigen (PSA) Testing Market Competitive Situation and Trends
3.6.1 Prostate-specific Antigen (PSA) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prostate-specific Antigen (PSA) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Prostate-specific Antigen (PSA) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2019-2024)
6.3 Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Prostate-specific Antigen (PSA) Testing Price by Type (2019-2024)
7 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prostate-specific Antigen (PSA) Testing Market Sales by Application (2019-2024)
7.3 Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Prostate-specific Antigen (PSA) Testing Sales Growth Rate by Application (2019-2024)
8 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Prostate-specific Antigen (PSA) Testing Sales by Region
8.1.1 Global Prostate-specific Antigen (PSA) Testing Sales by Region
8.1.2 Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Prostate-specific Antigen (PSA) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prostate-specific Antigen (PSA) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Prostate-specific Antigen (PSA) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prostate-specific Antigen (PSA) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Prostate-specific Antigen (PSA) Testing Basic Information
9.1.2 Abbott Prostate-specific Antigen (PSA) Testing Product Overview
9.1.3 Abbott Prostate-specific Antigen (PSA) Testing Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Prostate-specific Antigen (PSA) Testing SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Boston Scientific Corporation
9.2.1 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Basic Information
9.2.2 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Overview
9.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Market Performance
9.2.4 Boston Scientific Corporation Business Overview
9.2.5 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing SWOT Analysis
9.2.6 Boston Scientific Corporation Recent Developments
9.3 Bayer AG
9.3.1 Bayer AG Prostate-specific Antigen (PSA) Testing Basic Information
9.3.2 Bayer AG Prostate-specific Antigen (PSA) Testing Product Overview
9.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Product Market Performance
9.3.4 Bayer AG Prostate-specific Antigen (PSA) Testing SWOT Analysis
9.3.5 Bayer AG Business Overview
9.3.6 Bayer AG Recent Developments
9.4 Siemens Healthcare
9.4.1 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
9.4.2 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
9.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Market Performance
9.4.4 Siemens Healthcare Business Overview
9.4.5 Siemens Healthcare Recent Developments
9.5 DiaSorin
9.5.1 DiaSorin Prostate-specific Antigen (PSA) Testing Basic Information
9.5.2 DiaSorin Prostate-specific Antigen (PSA) Testing Product Overview
9.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Product Market Performance
9.5.4 DiaSorin Business Overview
9.5.5 DiaSorin Recent Developments
9.6 Roche
9.6.1 Roche Prostate-specific Antigen (PSA) Testing Basic Information
9.6.2 Roche Prostate-specific Antigen (PSA) Testing Product Overview
9.6.3 Roche Prostate-specific Antigen (PSA) Testing Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Beckman Coulter
9.7.1 Beckman Coulter Prostate-specific Antigen (PSA) Testing Basic Information
9.7.2 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Overview
9.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Market Performance
9.7.4 Beckman Coulter Business Overview
9.7.5 Beckman Coulter Recent Developments
9.8 PerkinElmer
9.8.1 PerkinElmer Prostate-specific Antigen (PSA) Testing Basic Information
9.8.2 PerkinElmer Prostate-specific Antigen (PSA) Testing Product Overview
9.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Product Market Performance
9.8.4 PerkinElmer Business Overview
9.8.5 PerkinElmer Recent Developments
9.9 Tosoh
9.9.1 Tosoh Prostate-specific Antigen (PSA) Testing Basic Information
9.9.2 Tosoh Prostate-specific Antigen (PSA) Testing Product Overview
9.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Product Market Performance
9.9.4 Tosoh Business Overview
9.9.5 Tosoh Recent Developments
9.10 Ortho Clinical
9.10.1 Ortho Clinical Prostate-specific Antigen (PSA) Testing Basic Information
9.10.2 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Overview
9.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Market Performance
9.10.4 Ortho Clinical Business Overview
9.10.5 Ortho Clinical Recent Developments
9.11 Fujirebio
9.11.1 Fujirebio Prostate-specific Antigen (PSA) Testing Basic Information
9.11.2 Fujirebio Prostate-specific Antigen (PSA) Testing Product Overview
9.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Product Market Performance
9.11.4 Fujirebio Business Overview
9.11.5 Fujirebio Recent Developments
9.12 Mediwatch
9.12.1 Mediwatch Prostate-specific Antigen (PSA) Testing Basic Information
9.12.2 Mediwatch Prostate-specific Antigen (PSA) Testing Product Overview
9.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Product Market Performance
9.12.4 Mediwatch Business Overview
9.12.5 Mediwatch Recent Developments
9.13 BodiTech
9.13.1 BodiTech Prostate-specific Antigen (PSA) Testing Basic Information
9.13.2 BodiTech Prostate-specific Antigen (PSA) Testing Product Overview
9.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Product Market Performance
9.13.4 BodiTech Business Overview
9.13.5 BodiTech Recent Developments
9.14 Bristol-Myers Squibb Company
9.14.1 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Basic Information
9.14.2 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Overview
9.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Market Performance
9.14.4 Bristol-Myers Squibb Company Business Overview
9.14.5 Bristol-Myers Squibb Company Recent Developments
9.15 GE Healthcare
9.15.1 GE Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
9.15.2 GE Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
9.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Product Market Performance
9.15.4 GE Healthcare Business Overview
9.15.5 GE Healthcare Recent Developments
9.16 Endocare
9.16.1 Endocare Prostate-specific Antigen (PSA) Testing Basic Information
9.16.2 Endocare Prostate-specific Antigen (PSA) Testing Product Overview
9.16.3 Endocare Prostate-specific Antigen (PSA) Testing Product Market Performance
9.16.4 Endocare Business Overview
9.16.5 Endocare Recent Developments
9.17 Merck?Co.
9.17.1 Merck?Co. Prostate-specific Antigen (PSA) Testing Basic Information
9.17.2 Merck?Co. Prostate-specific Antigen (PSA) Testing Product Overview
9.17.3 Merck?Co. Prostate-specific Antigen (PSA) Testing Product Market Performance
9.17.4 Merck?Co. Business Overview
9.17.5 Merck?Co. Recent Developments
9.18 Medtronic
9.18.1 Medtronic Prostate-specific Antigen (PSA) Testing Basic Information
9.18.2 Medtronic Prostate-specific Antigen (PSA) Testing Product Overview
9.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Product Market Performance
9.18.4 Medtronic Business Overview
9.18.5 Medtronic Recent Developments
9.19 Sanofi-Aventis SA
9.19.1 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Basic Information
9.19.2 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Overview
9.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Market Performance
9.19.4 Sanofi-Aventis SA Business Overview
9.19.5 Sanofi-Aventis SA Recent Developments
10 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET FORECAST BY REGION
10.1 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast
10.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region
10.2.4 South America Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Prostate-specific Antigen (PSA) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Prostate-specific Antigen (PSA) Testing by Type (2025-2030)
11.1.2 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Prostate-specific Antigen (PSA) Testing by Type (2025-2030)
11.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Prostate-specific Antigen (PSA) Testing Sales (K Units) Forecast by Application
11.2.2 Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Prostate-specific Antigen (PSA) Testing
1.2 Key Market Segments
1.2.1 Prostate-specific Antigen (PSA) Testing Segment by Type
1.2.2 Prostate-specific Antigen (PSA) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Prostate-specific Antigen (PSA) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Prostate-specific Antigen (PSA) Testing Sales by Manufacturers (2019-2024)
3.2 Global Prostate-specific Antigen (PSA) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Prostate-specific Antigen (PSA) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Prostate-specific Antigen (PSA) Testing Sales Sites, Area Served, Product Type
3.6 Prostate-specific Antigen (PSA) Testing Market Competitive Situation and Trends
3.6.1 Prostate-specific Antigen (PSA) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Prostate-specific Antigen (PSA) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Prostate-specific Antigen (PSA) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2019-2024)
6.3 Global Prostate-specific Antigen (PSA) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Prostate-specific Antigen (PSA) Testing Price by Type (2019-2024)
7 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Prostate-specific Antigen (PSA) Testing Market Sales by Application (2019-2024)
7.3 Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Prostate-specific Antigen (PSA) Testing Sales Growth Rate by Application (2019-2024)
8 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Prostate-specific Antigen (PSA) Testing Sales by Region
8.1.1 Global Prostate-specific Antigen (PSA) Testing Sales by Region
8.1.2 Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Prostate-specific Antigen (PSA) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Prostate-specific Antigen (PSA) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Prostate-specific Antigen (PSA) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Prostate-specific Antigen (PSA) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott
9.1.1 Abbott Prostate-specific Antigen (PSA) Testing Basic Information
9.1.2 Abbott Prostate-specific Antigen (PSA) Testing Product Overview
9.1.3 Abbott Prostate-specific Antigen (PSA) Testing Product Market Performance
9.1.4 Abbott Business Overview
9.1.5 Abbott Prostate-specific Antigen (PSA) Testing SWOT Analysis
9.1.6 Abbott Recent Developments
9.2 Boston Scientific Corporation
9.2.1 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Basic Information
9.2.2 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Overview
9.2.3 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Market Performance
9.2.4 Boston Scientific Corporation Business Overview
9.2.5 Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing SWOT Analysis
9.2.6 Boston Scientific Corporation Recent Developments
9.3 Bayer AG
9.3.1 Bayer AG Prostate-specific Antigen (PSA) Testing Basic Information
9.3.2 Bayer AG Prostate-specific Antigen (PSA) Testing Product Overview
9.3.3 Bayer AG Prostate-specific Antigen (PSA) Testing Product Market Performance
9.3.4 Bayer AG Prostate-specific Antigen (PSA) Testing SWOT Analysis
9.3.5 Bayer AG Business Overview
9.3.6 Bayer AG Recent Developments
9.4 Siemens Healthcare
9.4.1 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
9.4.2 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
9.4.3 Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Market Performance
9.4.4 Siemens Healthcare Business Overview
9.4.5 Siemens Healthcare Recent Developments
9.5 DiaSorin
9.5.1 DiaSorin Prostate-specific Antigen (PSA) Testing Basic Information
9.5.2 DiaSorin Prostate-specific Antigen (PSA) Testing Product Overview
9.5.3 DiaSorin Prostate-specific Antigen (PSA) Testing Product Market Performance
9.5.4 DiaSorin Business Overview
9.5.5 DiaSorin Recent Developments
9.6 Roche
9.6.1 Roche Prostate-specific Antigen (PSA) Testing Basic Information
9.6.2 Roche Prostate-specific Antigen (PSA) Testing Product Overview
9.6.3 Roche Prostate-specific Antigen (PSA) Testing Product Market Performance
9.6.4 Roche Business Overview
9.6.5 Roche Recent Developments
9.7 Beckman Coulter
9.7.1 Beckman Coulter Prostate-specific Antigen (PSA) Testing Basic Information
9.7.2 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Overview
9.7.3 Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Market Performance
9.7.4 Beckman Coulter Business Overview
9.7.5 Beckman Coulter Recent Developments
9.8 PerkinElmer
9.8.1 PerkinElmer Prostate-specific Antigen (PSA) Testing Basic Information
9.8.2 PerkinElmer Prostate-specific Antigen (PSA) Testing Product Overview
9.8.3 PerkinElmer Prostate-specific Antigen (PSA) Testing Product Market Performance
9.8.4 PerkinElmer Business Overview
9.8.5 PerkinElmer Recent Developments
9.9 Tosoh
9.9.1 Tosoh Prostate-specific Antigen (PSA) Testing Basic Information
9.9.2 Tosoh Prostate-specific Antigen (PSA) Testing Product Overview
9.9.3 Tosoh Prostate-specific Antigen (PSA) Testing Product Market Performance
9.9.4 Tosoh Business Overview
9.9.5 Tosoh Recent Developments
9.10 Ortho Clinical
9.10.1 Ortho Clinical Prostate-specific Antigen (PSA) Testing Basic Information
9.10.2 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Overview
9.10.3 Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Market Performance
9.10.4 Ortho Clinical Business Overview
9.10.5 Ortho Clinical Recent Developments
9.11 Fujirebio
9.11.1 Fujirebio Prostate-specific Antigen (PSA) Testing Basic Information
9.11.2 Fujirebio Prostate-specific Antigen (PSA) Testing Product Overview
9.11.3 Fujirebio Prostate-specific Antigen (PSA) Testing Product Market Performance
9.11.4 Fujirebio Business Overview
9.11.5 Fujirebio Recent Developments
9.12 Mediwatch
9.12.1 Mediwatch Prostate-specific Antigen (PSA) Testing Basic Information
9.12.2 Mediwatch Prostate-specific Antigen (PSA) Testing Product Overview
9.12.3 Mediwatch Prostate-specific Antigen (PSA) Testing Product Market Performance
9.12.4 Mediwatch Business Overview
9.12.5 Mediwatch Recent Developments
9.13 BodiTech
9.13.1 BodiTech Prostate-specific Antigen (PSA) Testing Basic Information
9.13.2 BodiTech Prostate-specific Antigen (PSA) Testing Product Overview
9.13.3 BodiTech Prostate-specific Antigen (PSA) Testing Product Market Performance
9.13.4 BodiTech Business Overview
9.13.5 BodiTech Recent Developments
9.14 Bristol-Myers Squibb Company
9.14.1 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Basic Information
9.14.2 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Overview
9.14.3 Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Market Performance
9.14.4 Bristol-Myers Squibb Company Business Overview
9.14.5 Bristol-Myers Squibb Company Recent Developments
9.15 GE Healthcare
9.15.1 GE Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
9.15.2 GE Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
9.15.3 GE Healthcare Prostate-specific Antigen (PSA) Testing Product Market Performance
9.15.4 GE Healthcare Business Overview
9.15.5 GE Healthcare Recent Developments
9.16 Endocare
9.16.1 Endocare Prostate-specific Antigen (PSA) Testing Basic Information
9.16.2 Endocare Prostate-specific Antigen (PSA) Testing Product Overview
9.16.3 Endocare Prostate-specific Antigen (PSA) Testing Product Market Performance
9.16.4 Endocare Business Overview
9.16.5 Endocare Recent Developments
9.17 Merck?Co.
9.17.1 Merck?Co. Prostate-specific Antigen (PSA) Testing Basic Information
9.17.2 Merck?Co. Prostate-specific Antigen (PSA) Testing Product Overview
9.17.3 Merck?Co. Prostate-specific Antigen (PSA) Testing Product Market Performance
9.17.4 Merck?Co. Business Overview
9.17.5 Merck?Co. Recent Developments
9.18 Medtronic
9.18.1 Medtronic Prostate-specific Antigen (PSA) Testing Basic Information
9.18.2 Medtronic Prostate-specific Antigen (PSA) Testing Product Overview
9.18.3 Medtronic Prostate-specific Antigen (PSA) Testing Product Market Performance
9.18.4 Medtronic Business Overview
9.18.5 Medtronic Recent Developments
9.19 Sanofi-Aventis SA
9.19.1 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Basic Information
9.19.2 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Overview
9.19.3 Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Market Performance
9.19.4 Sanofi-Aventis SA Business Overview
9.19.5 Sanofi-Aventis SA Recent Developments
10 PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING MARKET FORECAST BY REGION
10.1 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast
10.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region
10.2.4 South America Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Prostate-specific Antigen (PSA) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Prostate-specific Antigen (PSA) Testing by Type (2025-2030)
11.1.2 Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Prostate-specific Antigen (PSA) Testing by Type (2025-2030)
11.2 Global Prostate-specific Antigen (PSA) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Prostate-specific Antigen (PSA) Testing Sales (K Units) Forecast by Application
11.2.2 Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Prostate-specific Antigen (PSA) Testing Market Size Comparison by Region (M USD)
Table 5. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Prostate-specific Antigen (PSA) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2022)
Table 10. Global Market Prostate-specific Antigen (PSA) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Prostate-specific Antigen (PSA) Testing Sales Sites and Area Served
Table 12. Manufacturers Prostate-specific Antigen (PSA) Testing Product Type
Table 13. Global Prostate-specific Antigen (PSA) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Prostate-specific Antigen (PSA) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prostate-specific Antigen (PSA) Testing Market Challenges
Table 22. Global Prostate-specific Antigen (PSA) Testing Sales by Type (K Units)
Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (M USD)
Table 24. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Type (2019-2024)
Table 28. Global Prostate-specific Antigen (PSA) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) by Application
Table 30. Global Prostate-specific Antigen (PSA) Testing Market Size by Application
Table 31. Global Prostate-specific Antigen (PSA) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Prostate-specific Antigen (PSA) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2024)
Table 35. Global Prostate-specific Antigen (PSA) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Prostate-specific Antigen (PSA) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Prostate-specific Antigen (PSA) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Prostate-specific Antigen (PSA) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Prostate-specific Antigen (PSA) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Prostate-specific Antigen (PSA) Testing Basic Information
Table 44. Abbott Prostate-specific Antigen (PSA) Testing Product Overview
Table 45. Abbott Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Prostate-specific Antigen (PSA) Testing SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Basic Information
Table 50. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Overview
Table 51. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boston Scientific Corporation Business Overview
Table 53. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing SWOT Analysis
Table 54. Boston Scientific Corporation Recent Developments
Table 55. Bayer AG Prostate-specific Antigen (PSA) Testing Basic Information
Table 56. Bayer AG Prostate-specific Antigen (PSA) Testing Product Overview
Table 57. Bayer AG Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer AG Prostate-specific Antigen (PSA) Testing SWOT Analysis
Table 59. Bayer AG Business Overview
Table 60. Bayer AG Recent Developments
Table 61. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
Table 62. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
Table 63. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Siemens Healthcare Business Overview
Table 65. Siemens Healthcare Recent Developments
Table 66. DiaSorin Prostate-specific Antigen (PSA) Testing Basic Information
Table 67. DiaSorin Prostate-specific Antigen (PSA) Testing Product Overview
Table 68. DiaSorin Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. DiaSorin Business Overview
Table 70. DiaSorin Recent Developments
Table 71. Roche Prostate-specific Antigen (PSA) Testing Basic Information
Table 72. Roche Prostate-specific Antigen (PSA) Testing Product Overview
Table 73. Roche Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Beckman Coulter Prostate-specific Antigen (PSA) Testing Basic Information
Table 77. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Overview
Table 78. Beckman Coulter Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Beckman Coulter Business Overview
Table 80. Beckman Coulter Recent Developments
Table 81. PerkinElmer Prostate-specific Antigen (PSA) Testing Basic Information
Table 82. PerkinElmer Prostate-specific Antigen (PSA) Testing Product Overview
Table 83. PerkinElmer Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. PerkinElmer Business Overview
Table 85. PerkinElmer Recent Developments
Table 86. Tosoh Prostate-specific Antigen (PSA) Testing Basic Information
Table 87. Tosoh Prostate-specific Antigen (PSA) Testing Product Overview
Table 88. Tosoh Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Tosoh Business Overview
Table 90. Tosoh Recent Developments
Table 91. Ortho Clinical Prostate-specific Antigen (PSA) Testing Basic Information
Table 92. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Overview
Table 93. Ortho Clinical Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Ortho Clinical Business Overview
Table 95. Ortho Clinical Recent Developments
Table 96. Fujirebio Prostate-specific Antigen (PSA) Testing Basic Information
Table 97. Fujirebio Prostate-specific Antigen (PSA) Testing Product Overview
Table 98. Fujirebio Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Fujirebio Business Overview
Table 100. Fujirebio Recent Developments
Table 101. Mediwatch Prostate-specific Antigen (PSA) Testing Basic Information
Table 102. Mediwatch Prostate-specific Antigen (PSA) Testing Product Overview
Table 103. Mediwatch Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Mediwatch Business Overview
Table 105. Mediwatch Recent Developments
Table 106. BodiTech Prostate-specific Antigen (PSA) Testing Basic Information
Table 107. BodiTech Prostate-specific Antigen (PSA) Testing Product Overview
Table 108. BodiTech Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. BodiTech Business Overview
Table 110. BodiTech Recent Developments
Table 111. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Basic Information
Table 112. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Overview
Table 113. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bristol-Myers Squibb Company Business Overview
Table 115. Bristol-Myers Squibb Company Recent Developments
Table 116. GE Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
Table 117. GE Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
Table 118. GE Healthcare Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. GE Healthcare Business Overview
Table 120. GE Healthcare Recent Developments
Table 121. Endocare Prostate-specific Antigen (PSA) Testing Basic Information
Table 122. Endocare Prostate-specific Antigen (PSA) Testing Product Overview
Table 123. Endocare Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Endocare Business Overview
Table 125. Endocare Recent Developments
Table 126. Merck?Co. Prostate-specific Antigen (PSA) Testing Basic Information
Table 127. Merck?Co. Prostate-specific Antigen (PSA) Testing Product Overview
Table 128. Merck?Co. Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Merck?Co. Business Overview
Table 130. Merck?Co. Recent Developments
Table 131. Medtronic Prostate-specific Antigen (PSA) Testing Basic Information
Table 132. Medtronic Prostate-specific Antigen (PSA) Testing Product Overview
Table 133. Medtronic Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Medtronic Business Overview
Table 135. Medtronic Recent Developments
Table 136. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Basic Information
Table 137. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Overview
Table 138. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Sanofi-Aventis SA Business Overview
Table 140. Sanofi-Aventis SA Recent Developments
Table 141. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 142. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Prostate-specific Antigen (PSA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 144. North America Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Prostate-specific Antigen (PSA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 146. Europe Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 148. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Prostate-specific Antigen (PSA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 150. South America Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Prostate-specific Antigen (PSA) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 154. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Prostate-specific Antigen (PSA) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 156. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 157. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Prostate-specific Antigen (PSA) Testing Market Size Comparison by Region (M USD)
Table 5. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Prostate-specific Antigen (PSA) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-specific Antigen (PSA) Testing as of 2022)
Table 10. Global Market Prostate-specific Antigen (PSA) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Prostate-specific Antigen (PSA) Testing Sales Sites and Area Served
Table 12. Manufacturers Prostate-specific Antigen (PSA) Testing Product Type
Table 13. Global Prostate-specific Antigen (PSA) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Prostate-specific Antigen (PSA) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Prostate-specific Antigen (PSA) Testing Market Challenges
Table 22. Global Prostate-specific Antigen (PSA) Testing Sales by Type (K Units)
Table 23. Global Prostate-specific Antigen (PSA) Testing Market Size by Type (M USD)
Table 24. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Prostate-specific Antigen (PSA) Testing Market Size Share by Type (2019-2024)
Table 28. Global Prostate-specific Antigen (PSA) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) by Application
Table 30. Global Prostate-specific Antigen (PSA) Testing Market Size by Application
Table 31. Global Prostate-specific Antigen (PSA) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Prostate-specific Antigen (PSA) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2024)
Table 35. Global Prostate-specific Antigen (PSA) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Prostate-specific Antigen (PSA) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Prostate-specific Antigen (PSA) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Prostate-specific Antigen (PSA) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Prostate-specific Antigen (PSA) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Abbott Prostate-specific Antigen (PSA) Testing Basic Information
Table 44. Abbott Prostate-specific Antigen (PSA) Testing Product Overview
Table 45. Abbott Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbott Business Overview
Table 47. Abbott Prostate-specific Antigen (PSA) Testing SWOT Analysis
Table 48. Abbott Recent Developments
Table 49. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Basic Information
Table 50. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Product Overview
Table 51. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boston Scientific Corporation Business Overview
Table 53. Boston Scientific Corporation Prostate-specific Antigen (PSA) Testing SWOT Analysis
Table 54. Boston Scientific Corporation Recent Developments
Table 55. Bayer AG Prostate-specific Antigen (PSA) Testing Basic Information
Table 56. Bayer AG Prostate-specific Antigen (PSA) Testing Product Overview
Table 57. Bayer AG Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer AG Prostate-specific Antigen (PSA) Testing SWOT Analysis
Table 59. Bayer AG Business Overview
Table 60. Bayer AG Recent Developments
Table 61. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
Table 62. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
Table 63. Siemens Healthcare Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Siemens Healthcare Business Overview
Table 65. Siemens Healthcare Recent Developments
Table 66. DiaSorin Prostate-specific Antigen (PSA) Testing Basic Information
Table 67. DiaSorin Prostate-specific Antigen (PSA) Testing Product Overview
Table 68. DiaSorin Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. DiaSorin Business Overview
Table 70. DiaSorin Recent Developments
Table 71. Roche Prostate-specific Antigen (PSA) Testing Basic Information
Table 72. Roche Prostate-specific Antigen (PSA) Testing Product Overview
Table 73. Roche Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Roche Business Overview
Table 75. Roche Recent Developments
Table 76. Beckman Coulter Prostate-specific Antigen (PSA) Testing Basic Information
Table 77. Beckman Coulter Prostate-specific Antigen (PSA) Testing Product Overview
Table 78. Beckman Coulter Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Beckman Coulter Business Overview
Table 80. Beckman Coulter Recent Developments
Table 81. PerkinElmer Prostate-specific Antigen (PSA) Testing Basic Information
Table 82. PerkinElmer Prostate-specific Antigen (PSA) Testing Product Overview
Table 83. PerkinElmer Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. PerkinElmer Business Overview
Table 85. PerkinElmer Recent Developments
Table 86. Tosoh Prostate-specific Antigen (PSA) Testing Basic Information
Table 87. Tosoh Prostate-specific Antigen (PSA) Testing Product Overview
Table 88. Tosoh Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Tosoh Business Overview
Table 90. Tosoh Recent Developments
Table 91. Ortho Clinical Prostate-specific Antigen (PSA) Testing Basic Information
Table 92. Ortho Clinical Prostate-specific Antigen (PSA) Testing Product Overview
Table 93. Ortho Clinical Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Ortho Clinical Business Overview
Table 95. Ortho Clinical Recent Developments
Table 96. Fujirebio Prostate-specific Antigen (PSA) Testing Basic Information
Table 97. Fujirebio Prostate-specific Antigen (PSA) Testing Product Overview
Table 98. Fujirebio Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Fujirebio Business Overview
Table 100. Fujirebio Recent Developments
Table 101. Mediwatch Prostate-specific Antigen (PSA) Testing Basic Information
Table 102. Mediwatch Prostate-specific Antigen (PSA) Testing Product Overview
Table 103. Mediwatch Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Mediwatch Business Overview
Table 105. Mediwatch Recent Developments
Table 106. BodiTech Prostate-specific Antigen (PSA) Testing Basic Information
Table 107. BodiTech Prostate-specific Antigen (PSA) Testing Product Overview
Table 108. BodiTech Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. BodiTech Business Overview
Table 110. BodiTech Recent Developments
Table 111. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Basic Information
Table 112. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Product Overview
Table 113. Bristol-Myers Squibb Company Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bristol-Myers Squibb Company Business Overview
Table 115. Bristol-Myers Squibb Company Recent Developments
Table 116. GE Healthcare Prostate-specific Antigen (PSA) Testing Basic Information
Table 117. GE Healthcare Prostate-specific Antigen (PSA) Testing Product Overview
Table 118. GE Healthcare Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. GE Healthcare Business Overview
Table 120. GE Healthcare Recent Developments
Table 121. Endocare Prostate-specific Antigen (PSA) Testing Basic Information
Table 122. Endocare Prostate-specific Antigen (PSA) Testing Product Overview
Table 123. Endocare Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Endocare Business Overview
Table 125. Endocare Recent Developments
Table 126. Merck?Co. Prostate-specific Antigen (PSA) Testing Basic Information
Table 127. Merck?Co. Prostate-specific Antigen (PSA) Testing Product Overview
Table 128. Merck?Co. Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Merck?Co. Business Overview
Table 130. Merck?Co. Recent Developments
Table 131. Medtronic Prostate-specific Antigen (PSA) Testing Basic Information
Table 132. Medtronic Prostate-specific Antigen (PSA) Testing Product Overview
Table 133. Medtronic Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Medtronic Business Overview
Table 135. Medtronic Recent Developments
Table 136. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Basic Information
Table 137. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Product Overview
Table 138. Sanofi-Aventis SA Prostate-specific Antigen (PSA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Sanofi-Aventis SA Business Overview
Table 140. Sanofi-Aventis SA Recent Developments
Table 141. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 142. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America Prostate-specific Antigen (PSA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 144. North America Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe Prostate-specific Antigen (PSA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 146. Europe Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 148. Asia Pacific Prostate-specific Antigen (PSA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America Prostate-specific Antigen (PSA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 150. South America Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa Prostate-specific Antigen (PSA) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa Prostate-specific Antigen (PSA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 154. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global Prostate-specific Antigen (PSA) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 156. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 157. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Prostate-specific Antigen (PSA) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Size (M USD), 2019-2030
Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prostate-specific Antigen (PSA) Testing Market Size by Country (M USD)
Figure 11. Prostate-specific Antigen (PSA) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Manufacturers in 2023
Figure 13. Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Prostate-specific Antigen (PSA) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Prostate-specific Antigen (PSA) Testing Market Share by Type
Figure 18. Sales Market Share of Prostate-specific Antigen (PSA) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Prostate-specific Antigen (PSA) Testing by Type in 2023
Figure 20. Market Size Share of Prostate-specific Antigen (PSA) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Prostate-specific Antigen (PSA) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prostate-specific Antigen (PSA) Testing Market Share by Application
Figure 24. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Application in 2023
Figure 26. Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2024)
Figure 27. Global Prostate-specific Antigen (PSA) Testing Market Share by Application in 2023
Figure 28. Global Prostate-specific Antigen (PSA) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Prostate-specific Antigen (PSA) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Prostate-specific Antigen (PSA) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Prostate-specific Antigen (PSA) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Prostate-specific Antigen (PSA) Testing Sales Market Share by Country in 2023
Figure 37. Germany Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales Market Share by Region in 2023
Figure 44. China Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 50. South America Prostate-specific Antigen (PSA) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Prostate-specific Antigen (PSA) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Prostate-specific Antigen (PSA) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Prostate-specific Antigen (PSA) Testing Market Size (M USD), 2019-2030
Figure 5. Global Prostate-specific Antigen (PSA) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Prostate-specific Antigen (PSA) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Prostate-specific Antigen (PSA) Testing Market Size by Country (M USD)
Figure 11. Prostate-specific Antigen (PSA) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Prostate-specific Antigen (PSA) Testing Revenue Share by Manufacturers in 2023
Figure 13. Prostate-specific Antigen (PSA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Prostate-specific Antigen (PSA) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Prostate-specific Antigen (PSA) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Prostate-specific Antigen (PSA) Testing Market Share by Type
Figure 18. Sales Market Share of Prostate-specific Antigen (PSA) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Prostate-specific Antigen (PSA) Testing by Type in 2023
Figure 20. Market Size Share of Prostate-specific Antigen (PSA) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Prostate-specific Antigen (PSA) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Prostate-specific Antigen (PSA) Testing Market Share by Application
Figure 24. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Application in 2023
Figure 26. Global Prostate-specific Antigen (PSA) Testing Market Share by Application (2019-2024)
Figure 27. Global Prostate-specific Antigen (PSA) Testing Market Share by Application in 2023
Figure 28. Global Prostate-specific Antigen (PSA) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Prostate-specific Antigen (PSA) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Prostate-specific Antigen (PSA) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Prostate-specific Antigen (PSA) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Prostate-specific Antigen (PSA) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Prostate-specific Antigen (PSA) Testing Sales Market Share by Country in 2023
Figure 37. Germany Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Prostate-specific Antigen (PSA) Testing Sales Market Share by Region in 2023
Figure 44. China Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 50. South America Prostate-specific Antigen (PSA) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Prostate-specific Antigen (PSA) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Prostate-specific Antigen (PSA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Prostate-specific Antigen (PSA) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Prostate-specific Antigen (PSA) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Prostate-specific Antigen (PSA) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Prostate-specific Antigen (PSA) Testing Market Share Forecast by Application (2025-2030)
